The anxiolytic-like effect of nicotine undergoes rapid tolerance in a model of contextual fear conditioning in rats

Pharmacology Biochemistry and Behavior

Volumn 69, Issue 3-4, 2001, Pages 511-518

  Szyndler, J ^a   Sienkiewicz Jarosz, H ^b   Maciejak, P ^b   Siemitkowski M ^b   Rokicki, D ^a   Czlonkowska, A I ^a   Planik A ^a,b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Contextual fear conditioning; Locomotor activity; Nicotine; Pain threshold; Rats; Tolerance

Indexed keywords

ANXIOLYTIC AGENT; MIDAZOLAM MALEATE; NICOTINE; NICOTINE TARTRATE; NICOTINIC RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; DRUG TOLERANCE; FEAR; FREEZING; JUMPING; LOCOMOTION; MALE; MODEL; NONHUMAN; OPEN FIELD TEST; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; TRAINING; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; CONDITIONING (PSYCHOLOGY); DRUG TOLERANCE; FEAR; MALE; MOTOR ACTIVITY; NICOTINE; NICOTINIC AGONISTS; RATS; RATS, WISTAR;

ANIMALIA;

EID: 0034872628     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(01)00548-2     Document Type: Article

References (40)

1. Conditioned fear-induced changes in behavior and in the expression of the immediate early gene c-fos: With and without diazepam treatment
2. The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity
3. Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus maze test
4. Anxiolytic-like effects of the novel cholinergic channel activator ABT-418
5. Neuronal nicotinic receptors, important new players in brain function
6. The actions of nicotine and cocaine in a mouse model of anxiety
7. (S)-3-Methyl-5(1-methyl-2-pyrrolidynyl)isoxazole (ABT 418): A novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterisation
8. Acute and chronic effects of nornicotine on locomotor activity in rats: Altered response to nicotine
9. Nicotine induces disinhibitory behavior in the rat after subchronic peripheral nicotinic acetylcholine receptor blockade
10. Effects of repeated nicotine pre-treatment on mesoprefrontal dopaminergic and behavioral responses to acute footshock stress
11. Effects of repeated nicotine administration and footshock stress on rat mesoprefrontal dopamine systems: Evidence for opioid mechanisms
12. Residence times and half-lives of nicotine metabolites in rat brain after acute peripheral administration of [2′-(14)C]nicotine
13. Nicotine enhancement of contextual fear conditioning
14. Benzodiazepine-induced amnesia in rats: Reinstatement of conditioned performance by noxious stimulation on test
15. Influence of mecamylamine and atropine on tolerance development to nicotine hypothermia in rats
16. Serotonergic activation reduces defensive freezing in the conditioned fear paradigm
17. Time course of changes in the social interaction test of anxiety following acute and chronic administration of nicotine
18. 3H]GABA) release from rat hippocampal slices by nicotinic receptor activation
19. 3H]acetylcholine to nicotinic receptors
20. Fear and the brain: Where have we been, and where are we going
21. Development of nicotinic drug therapy for cognitive disorders
22. Chronic nicotine stimulation and blockade effects on working memory
23. Neuronal nicotinic acetylcholine receptors as novel drug targets
24. Pharmacological characterisation of nicotinic receptor stimulated GABA release from mouse brain synaptosomes
25. Monoamine oxidase inhibitors reduce conditioned fear stress-induced freezing behavior in rats
26. Discrimination of agonist-antagonist mixtures: Experiments with nicotine plus mecamylamine
27. Nicotinic receptor knockout mice as animal models for studying receptor function
28. Mecamylamine blocks the development of tolerance to nicotine in rats: Implications for the mechanisms of tolerance
29. 3H]epibatidine binding in response to repeated nicotine administration in rats
30. Effect of subchronic lithium carbonate and MKC-242 in conditioned fear stress in rats
31. Contextual fear conditioning is associated with an increase of acetylcholine release in the hippocampus of rats
32. Behavioral sensitization to nicotine is associated with behavioral disinhibition: Counteraction with citalopram
33. Chronic and acute tolerance to subjective, behavioural and cardiovascular effects of nicotine in humans
34. Nicotinic receptors in the brain: Links between molecular biology and behavior
35. Pharmacological characterization of nicotine-induced acetylcholine release in the rat hippocampus in vivo: Evidence for a permissive dopamine synapse
36. Effects of nicotine, mecamylamine, and hexamethonium on shock induced fighting, pain reactivity, and locomotor behaviour in rats
37. The effects of physostigmine and cholinergic receptor ligands on novelty-induced neophobia
38. Locomotor activation and dopamine release produced by nicotine and isoarecolone in rats
39. Antinociceptive effect of chronic nicotine and nociceptive effect of its withdrawal measured by hot-plate and tail-flick in rats
40. Effects of conditioned fear stress on 5-HT release in the rat prefrontal cortex